Contemporary ACS antithrombotic therapy

With an unrestricted educational grant from THE MEDICINES COMPANY

Chairpersons: P.G. Steg, C.M. Gibson



Click here to watch the VIDEO

Learning Objectives

  • To discuss the upgraded role of effective thrombin and P2Y12 inhibition in ACS management
  • To discuss contemporary therapeutic options and latest trial evidence supporting the guidelines
  • To discuss the need for teamwork and leadership to further improve outcomes

Presentations available when logged in:

  • The foundation for successfully running an interventional cardiology system
  • Understanding the crucial targets for antithrombotic therapy in ACS
  • State-of-the-art therapeutic options in the acute setting
  • Effective anticoagulation for high-risk PCI: where getting it right really counts